Drugs / Influenza virus (split virion, inactivated) vaccine
Influenza virus (split virion, inactivated) vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00946179 | May → Jun 2009 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Influenza virus (split virion, inactivated) vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00946179 ↗ |
| Modality | Vaccine | “Influenza virus (split virion, inactivated) vaccine” NCT00946179 ↗ |
| Route | Intramuscular | “0.5 mL, Intramuscular” NCT00946179 ↗ |